Ph.D. Alumni Bios: Private Sector


  1. Home


  2. Academic Experience


  3. Academic Programs


  4. Health Services Doctor of Philosophy


  5. Careers: Health Services PhD


  6. PhD Alumni Bios


  7. Ph.D. Alumni Bios: Private Sector

These are bios for UW Health Services Ph.D. alumni who work in the private sector. Contact us to learn more about how you can potentially connect with these alumni for advice, mentorship, or open positions at their organization.

Alex Bohl | Data Analytics, Mathematica Policy Research

Researcher, Data Analytics, Mathematica Policy Research

Alex Bohl began his studies in the Health Services PhD program in 2007. Bohl pursued an area of emphasis in Informatics, Economics and Evaluation Sciences, and worked closely with Paul Fishman to complete his dissertation, “The cost implications of fall-related injuries,” before graduating in 2011.

At present, Bohl works as a Researcher in Data Analytics at Mathematica Policy Research. Bohl works on projects related to statistical modeling of hospital quality, the cost and quality of care for Medicaid beneficiaries using long-term services and supports (LTSS), establishing bundled payment methodologies, and risk-adjusting managed LTSS plan rates.

Emily Dolan | American Society for the Prevention of Cruelty to Animals (ASPCA)

Director of Applied Research, American Society for the Prevention of Cruelty to Animals (ASPCA)

Emily Dolan began her studies in the Health Services PhD program in 2004, and was an AHRQ and BCPT trainee while in the program. Dolan pursued an area of emphasis in Evaluation Sciences, and worked closely with Bonnie McGregor to complete her dissertation, “Potential biobehavioral mediators of the relationship between predisposing factors and health outcomes in women,” before graduating in 2009.

At present, Dolan works as a Director of Research for the American Society for the Prevention of Cruelty to Animals. Dolan’s research focuses on keeping pets and people together and increasing access to veterinary care in underserved communities.

Colleen Daly | Global Occupational Health, Microsoft Corporation

Director, Global Occupational Health, Safety and Research, Microsoft Corporation

Colleen Daly began her studies in the Health Services PhD program in 2003, and was a NIOSH trainee while in the program.

Daly pursued an area of emphasis in Occupational Health and Safety, and worked closely with Tom Wickizer, to complete her dissertation, “Does changing work organization through telecommuting affect individual health? A focus on stress and health behavior,” before graduating in 2007.

Daly enjoys everything about the Northwest, from paddling boarding in the summer to skiing in the winter.

Benjamin Ely | Data Scientist, Amazon

Data Scientist, Amazon

His research interests include personalized medicine, translational research, and economic evaluation of health innovations.

Prior to enrolling in the doctoral program, Ben graduated from the University of Washington with an MS in Biostatistics. He worked as a biostatistician at the Fred Hutchinson Cancer Research Center and as a performance engineer at Amazon.com.

During his doctoral studies, Ben pursued Areas of Emphasis in Health Economics and in Evaluative Sciences and Statistics. He worked closely with his Chair, Anirban Basu, to complete his dissertaton, “Antibiotics and acute respiratory tract infections: An evaluation of the CDC’s Get Smart about Antibiotics campaign,” before graduating in 2018. Ben was an Agency for Healthcare Research and Quality trainee for 2014-2015.

Kelly McCarrier | Senior Research Scientist, Health Research Associates

Senior Research Scientist, Health Research Associates

Kelly McCarrier earned his PhD in Health Services from the University of Washington in 2009, and his MPH from the University of Arizona in 2003. He worked closely with his Chair, Diane Martin, on his dissertation research examining patients’ experiences with web-based co-management programs for diabetes, and investigated the effects of minimum wage policies on healthcare access. McCarrier pursued his doctoral area of emphasis in Evaluation Sciences and Statistics.

Before beginning his doctoral studies, he served as an evaluation research fellow with the Centers for Disease Control and Prevention (CDC), conducting qualitative research and program evaluation projects within the Division of TB Elimination. Kelly is a member of ISOQOL and ISPOR, and has authored recent publications on the use of novel qualitative research techniques and mixed-methods approaches in the development of PRO instruments.

Kelly McCarrier is the Senior Research Scientist at Health Research Associates (HRA), where he has over a decade of experience in qualitative and mixed-methods development and evaluation of clinical outcome assessment (COA) tools. Since joining HRA in 2006, he has served as a principal investigator, coordinator, qualitative interviewer, analyst, and research methodologist on over 70 projects to develop and validate patient-reported outcome (PRO) instruments across a wide variety of health conditions. Recently, Kelly has helped to lead HRA’s instrument-development collaborations with both the Depression and NSCLC Working Groups of the PRO Consortium.

Song Wang | Health Economics and Outcomes Research, AbbVie

Senior Manager, Department of Health Economics and Outcomes Research, AbbVie

Song Wang began his studies in the Health Services PhD program in 2005. Wang pursued an area of emphasis in Evaluation Sciences, and worked closely with Doug Conrad to complete his dissertation, “Impact of Washington State Diabetes Collaborative III on patient economic outcomes and medication adherence,” before graduating in 2010.

At present, Wang works as a Senior Manager at AbbVie in the Department of Health Economics & Outcomes Research leading the research in gastroenterology for global markets.

Wang has worked in biopharmaceutical industry in the HEOR field since graduation and published peer-reviewed journal manuscripts as well as poster/podium presentations at clinical conferences in disease areas such as colorectal cancer, pancreatic cancer, melanoma, and inflammatory bowel disease.